Description
Clinical trial statistics to HSA and ICH guidelines
Clinical trial analysis must follow a pre-specified plan and be reported transparently to the standard regulators and journals expect. This service provides specialised statistical analysis for clinical trials in line with HSA and ICH guidelines, delivered by biostatisticians experienced with HSA requirements and working to GCP.
What you receive
- Statistical input on design, randomisation and sample size
- A statistical analysis plan aligned with the protocol
- GCP-compliant analyses, including intention-to-treat and per-protocol populations
- Analysis of primary and secondary endpoints as pre-specified
- Tables, listings and figures and CONSORT-compliant reporting
- Reproducible code and outputs
- Invoices suitable for MOE and NRF grant claims
How it works
- Review of the protocol, data and research questions with your team
- Preparation or review of the SAP before unblinding
- Analysis and production of tables, listings and figures
- Delivery of the report with an explanation of results and revisions on request
Standards we follow
Analyses follow ICH E9 and ICH E6 (GCP), HSA guidance and CONSORT reporting, in line with COPE and ICMJE.
Turnaround and price
US$1,405 (approximately S$1,790; exchange rates may vary). MOE/NRF-compliant invoices are available. Turnaround is confirmed after data review, based on study size and your deadline.
Frequently asked questions
Can you help if data collection is complete but there is no SAP?
Yes. We prepare the SAP before examining outcomes and document every decision for transparency.
How is patient data handled?
We work only with de-identified data and follow the conditions approved by your IRB, in line with the Human Biomedical Research Act where it applies.
Questions before ordering? Contact our team or request a quote.


